Custo-benefício das alternativas às transfusões de sangue
Obstetrícia
Methods of bloodless care, clinical outcomes, and costs for adult patients who decline allogeneic transfusions. (abre nova janela)
Fonte: Anesth Analg 2022;135(3):576-85.
Indexado: PubMed 35977366
DOI: 10.1213/ANE.0000000000006114
https://www.ncbi.nlm.nih.gov/pubmed/35977366 (abre nova janela)
Tranexamic acid for treatment of women with post-partum haemorrhage in Nigeria and Pakistan: a cost-effectiveness analysis of data from the WOMAN trial. (abre nova janela)
Fonte: Lancet Glob Health 2018;6(2):e222-8.
Indexado: PubMed 29389542
DOI: 10.1016/S2214-109X(17)30467-9
https://www.ncbi.nlm.nih.gov/pubmed/29389542 (abre nova janela)
Cost-effectiveness analysis of intraoperative cell salvage for obstetric hemorrhage. (abre nova janela)
Fonte: Anesthesiology 2018;128(2):328-37.
Indexado: PubMed 29194062
DOI: 10.1097/ALN.0000000000001981
https://www.ncbi.nlm.nih.gov/pubmed/29194062 (abre nova janela)
Intra-operative cell salvage in South Africa: feasible, beneficial and economical. (abre nova janela)
Fonte: S Afr Med J 2013;103(10):754-7.
Indexado: PubMed 24079629
https://www.ncbi.nlm.nih.gov/pubmed/24079629 (abre nova janela)
Obstetric intra-operative cell salvage: a review of an established cell salvage service with 1170 re-infused cases. (abre nova janela)
Fonte: Anaesthesia 2019;74(8):976-83.
Indexado: PubMed 30912123
DOI: 10.1111/anae.14630
https://www.ncbi.nlm.nih.gov/pubmed/30912123 (abre nova janela)